featured
Effect of Concomitant Medications With Immunomodulatory Properties on Outcomes in Advanced Cancer Treated With Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Concomitant Medications With Immune-Modulatory Properties on the Outcomes of Patients With Advanced Cancer Treated With Immune Checkpoint Inhibitors: Development and Validation of a Novel Prognostic Index
Eur. J. Cancer 2021 Jan 01;142(xx)18-28, S Buti, M Bersanelli, F Perrone, M Tiseo, M Tucci, V Adamo, LS Stucci, A Russo, ET Tanda, F Spagnolo, F Rastelli, F Pergolesi, D Santini, M Russano, C Anesi, R Giusti, M Filetti, P Marchetti, A Botticelli, A Gelibter, MA Occhipinti, M Ferrari, MG Vitale, L Nicolardi, R Chiari, E Rijavec, O Nigro, A Tuzi, M De Tursi, P Di Marino, F Conforti, P Queirolo, S Bracarda, S Macrini, S Gori, F Zoratto, E Veltri, B Di Cocco, D Mallardo, MG Vitale, M Santoni, L Patruno, G Porzio, C Ficorella, DJ Pinato, PA Ascierto, A CortelliniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.